ArticleTranslational gastroenterology and hepatology2026
Fedratinib treatment correlates with suppressed STAT3/AKT/calpain-1 signaling and inhibits hepatocellular carcinoma progression.
Yunyang Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.